2024
The impact of obesity, age, and gender on plasmatic levels of selected glycoprotein biomarkers and miRNA-499 in OSA patients
KOSTLIVY, Tomas, Martin PESTA, Jindra WINDRICHOVA, Petr SKOPEK, Pavel KLAIL et. al.Základní údaje
Originální název
The impact of obesity, age, and gender on plasmatic levels of selected glycoprotein biomarkers and miRNA-499 in OSA patients
Autoři
KOSTLIVY, Tomas (203 Česká republika), Martin PESTA (203 Česká republika), Jindra WINDRICHOVA (203 Česká republika), Petr SKOPEK (203 Česká republika), Pavel KLAIL (203 Česká republika), Alena SKALOVA (203 Česká republika), Břetislav GÁL (203 Česká republika, domácí), Radek KUCERA (203 Česká republika), Krista PLICKOVA (203 Česká republika), Vaclav SIMANEK (203 Česká republika) a David SLOUKA (203 Česká republika)
Vydání
Journal of applied biomedicine, České Budějovice, Faculty of Health and Social Care, University of South Bohemia, 2024, 1214-021X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30206 Otorhinolaryngology
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.300 v roce 2022
Organizační jednotka
Lékařská fakulta
UT WoS
001246575700001
Klíčová slova anglicky
Biomarkers; Diagnostic process; microRNA; Obstructive sleep apnoea
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 11. 2024 14:15, Mgr. Tereza Miškechová
Anotace
V originále
Background: The current obstructive sleep apnea (OSA) diagnostic uses polysomnography or limited polygraphy and requires specialized personnel and technical equipment. Glycoprotein biomarkers and microRNAs are being explored as a possible new method for screening. We aimed to evaluate whether certain biomarkers and microRNA, previously identified as related to OSA, could be influenced by factors such as gender, age, and obesity level in patients with OSA. Methods: In this retrospective analytical study, patients with moderate to severe OSA (n = 130) were compared with the control group. Serum levels of selected biomarkers and microRNA were taken from both groups. The group of OSA patients was then stratified by gender, obesity level, and age to see the possible influence of those variables on biomarker levels. Results: Levels of all studied biomarkers - C-reactive protein (CRP), high-sensitivity troponin I (hsTnI), pentraxin-3 (PTX-3), and microRNA-499 were significantly higher in patients with OSA compared to the control group. In the OSA group only hsTnI showed a statistically significant relationship with gender. Levels of CRP and hsTnI showed a significant dependence on the level of obesity. Dependency on age was proven for hsTnI. CRP, PTX-3, and microRNA-499 did not have any statistically significant relationship with age. Conclusion: We found that serum levels of pentraxin-3 and microRNA-499 in patients with moderate to severe obstructive sleep apnoea are independent of gender, obesity, and age. CRP was affected by the level of obesity and hsTnI was influenced by all 3 variables. We consider these findings important for further research of OSA biomarkers.
Návaznosti
90125, velká výzkumná infrastruktura |
|